Application of a correlation correction factor in a microarray cross-platform reproducibility study-5

<p><b>Copyright information:</b></p><p>Taken from "Application of a correlation correction factor in a microarray cross-platform reproducibility study"</p><p>http://www.biomedcentral.com/1471-2105/8/447</p><p>BMC Bioinformatics 2007;8():447-447.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2211756.</p><p></p>on among the three platforms

Application of a correlation correction factor in a microarray cross-platform reproducibility study-1

<p><b>Copyright information:</b></p><p>Taken from "Application of a correlation correction factor in a microarray cross-platform reproducibility study"</p><p>http://www.biomedcentral.com/1471-2105/8/447</p><p>BMC Bioinformatics 2007;8():447-447.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2211756.</p><p></p>n among the three platforms

Application of a correlation correction factor in a microarray cross-platform reproducibility study-0

<p><b>Copyright information:</b></p><p>Taken from "Application of a correlation correction factor in a microarray cross-platform reproducibility study"</p><p>http://www.biomedcentral.com/1471-2105/8/447</p><p>BMC Bioinformatics 2007;8():447-447.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2211756.</p><p></p> to the 1,288 genes in common among the three platforms

Application of a correlation correction factor in a microarray cross-platform reproducibility study-3

<p><b>Copyright information:</b></p><p>Taken from "Application of a correlation correction factor in a microarray cross-platform reproducibility study"</p><p>http://www.biomedcentral.com/1471-2105/8/447</p><p>BMC Bioinformatics 2007;8():447-447.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2211756.</p><p></p> to the 1,288 genes in common among the three platforms

MN frequencies for discordant MZ twin pairs and age-matched controls.

<p>The mean level is indicated by a horizontal bar for controls (mean [SD] 14.2 [9.4]), CSA nonexposed (14.9 [5.6]) and CSA exposed (22.0 [11.3]) twins. CSA exposure status was significant in this combined sample (<i>P</i><0.001), while there was no indication of an additional effect attributable to the familial environment (<i>P = </i>0.406) based on results from generalized mixed-effect models.</p

Relationship between MN frequency and age for CSA exposed and nonexposed twins.

<p>A significant interaction effect was observed (coefficient [SE] = 0.030 [0.009], <i>P</i> = 0.0006) with the MN level in CSA exposed twins increasing with age while the MN level remained constant across the limited age range evaluated in CSA nonexposed twins.</p

Lifestyle characteristics and adult psychiatric and substance use disorders in CSA discordant MZ twin pairs.

1<p>indicates pairs discordant for CSA and item where the exposed twin was positive for the item (n₂₁).</p>2<p>indicates pairs discordant for CSA and item where the nonexposed twin was positive for the item (n₁₂).</p>3<p>odds ratio for twin pairs doubly discordant for CSA and item (n₂₁/n₁₂).</p>4<p>prescription and non-prescription use for more than 1 year excluding birth control.</p><p>+/− ∞, value is positive/negative and infinite due to a null value in at least one category.</p>*<p>two-sided P value from exact binomial test.</p